References

1. Apitz C, Webb GD, Redington AN. Tetralogy of fallot. Lancet.

2009;374:1462-71
2. Fox D, Devendra GP, Hart SA, Krasuski RA. When blue babies grow up:
what you need to know about tetralogy of fallot. Cleve Clin J Med.
2010;77:821-8.
3. Ho KW, Tan RS, Wong KY, Tan TH, Shankar S, Tan JL. Late
complications following tetralogy of fallot repair: the need for long-term
follow up. Ann Acad Med. 2007;36:947-53.
4. Bailliard F, Anderson RH. Tetralogy of fallot. Orphanet J Rare Dis.
2009;13:2
5. Gaude GS. Hemoptysis in children. Indian Pediatr. 2010;47:245-54
6. Toker A, Tanju S, Bayrak Y, Cenesiz E, Guler N, Dilege S, et al. Lifethreatening hemoptysis in a child: the only symptom. Ann Thorac Surg.
2004;77:336-8
7. Coss-Bu JA, Sachdeva RC, Bricker JT, Harrison GM, Jefferson LS.
Hemoptysis: a 10-year retrospective study. Pediatrics. 1997;100: 7
8. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic
congenital heart disease. J Cardiothorac Vasc Anesth. 2002;16:752-65.
9. Puspitasari F, Harimurti GM. Hyperviscoucity in cyanotic congenital heart
disease. J Kardiol Indones. 2010;31:41-7.
10. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in
cyanotic congenital heart disease. Am J Cardiol. 2006;98:254-8
11. Goel M, Shome DK, Singh ZN, Bhattacharjee J, Khalil A. Haemostatic
changes in children with cyanotic and acyanotic congenital heart disease.
Indian Heart J. 2000;52:559-63.
12. Kejariwal D, Sarkar N, Roy S, Bhattacharya M. Fallots tetralogy
presenting with variceal bleed. J Postgrad Med. 2001;47:194-5.
13. Mahajan N, Kondur A, Afonso L. Gastrointestinal bleeding in tetralogy of
fallot. Oman Med J. 2008;23:187-8.

21

14. Brodsky I,Gill DN, Lusch CJ. Fibrinolysis in congenital heart disease:
Preoperative treatment with aminocaproic acid. Am J Clin Pathol.
1969;51:51-7.
15. Rokicki W, Strzalkowski A, Klapcinska B, Danch A, Sobczak A.
Antioxidant status in newborns and infants suffering from congenital heart
defects. Wiad Lek. 2003;56:337-40.
16. Stocker R, Keaney JF. New insights on oxidative stress in the artery wall.
J Thromb Haemost. 2005;3:1825-34.
17. Ercan S, Cakmak A, Kosecik M, Erel O. The oxidative state of children
with cyanotic and acyanotic congenital heart disease. Anadolu Kardiyol
Derg. 2009;9:486-90.
18. Cumming GR. Propranolol in tetralogy of fallot. Circ Cardiovasc Genet.
1970;41:13-5.
19. Jackson DP. Hemorrhagic diathesis in patients with cyanotic congenital
heart disease: preoperative

management.

Ann

N Y Acad Sci.

1964;115:235-51.
20. Territo MC, Rosove MH. Cyanotic congenital heart disease : hematologic
management. J Am Coll Cardiol. 1991;18:320-2.

22